sCD14 and intestinal fatty acid binding protein are elevated in the serum of patients with idiopathic anaphylaxis.

Elsevier

Available online 29 March 2023

The Journal of Allergy and Clinical Immunology: In PracticeAuthor links open overlay panel, , , , , , , Abstract:Background

Intestinal epithelial integrity compromise has been identified in gastrointestinal (GI), atopic, and autoimmune diseases.

Objective

Episodes of idiopathic anaphylaxis (IA) are often accompanied by GI manifestations. We therefore sought to determine whether surrogate markers of GI permeability were aberrant in this patient population.

Methods

Serum concentrations of zonulin, intestinal fatty acid binding protein (I-FABP), and soluble CD14 (sCD14) measured in 54 patients with IA were compared to concentrations in healthy controls (HCs); and correlated with clinical and laboratory parameters.

Results

I-FABP was elevated in sera of patients with IA compared to HCs (median 1378.0 pg/mL vs 479.0 pg/mL respectively, p < 0.001). sCD14 was also elevated compared to HCs (median 2017.0 ng/mL and 1189.0 ng/mL respectively, p <0.001), whereas zonulin was comparable between patients with IA and HCs (median 49.6 ng/mL vs 52.4 ng/mL respectively, p = 0.40). I-FABP was elevated in patients with IA who experienced vomiting and/or diarrhea compared to patients with IA who did not (p = 0.0091).

Conclusion

I-FABP and sCD14 are elevated in the serum of patients with IA. Elevations in these biomarkers of IA provides evidence that increased gastrointestinal permeability, as is observed in other allergic conditions such as food allergy, is a common finding in those with IA and offers possible insight into the pathogenesis of this disease.

View full text

© 2023 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology

留言 (0)

沒有登入
gif